SANGAMO THERAPEUTICS, INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sangamo Therapeutics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $10.7M.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$135M, a 46% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$258M, a 34.1% decline from 2022.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$192M, a 7.85% decline from 2021.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$178M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$258M -$65.6M -34.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$192M -$14M -7.85% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$178M -$57.3M -47.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 -$121M -$25.8M -27.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$95.2M -$26.9M -39.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$68.3M -$13.8M -25.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$54.6M +$17.1M +23.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$71.7M -$31M -76.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$40.7M -$14.3M -54.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$26.4M +$207K +0.78% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$26.6M -$4.36M -19.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-18
2012 -$22.3M +$13.5M +37.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 -$35.8M -$10.9M -43.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 -$24.9M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.